Investment

TRAVERE THERAPEUTICS INC

Historical 13F holders

CUSIP
89422GAA5
Type
Debt
Class
NOTE 2.250% 3/0
Period 13F filings
2026 Q1 1
2025 Q4 3
2025 Q3 4
2025 Q2 2
2025 Q1 4
2024 Q4 3
2024 Q3 3